Evidence map›Paper›PMID 39313372›Full record

ArticleThe Journal of reproduction and development2024

MiR-145-5p regulates granulosa cell proliferation by targeting the

Gao Lingling, Yang Qingxing, Xu Jianbo, Wang Weijie, Lu Dan

Abstract read
In one paragraph

Article in The Journal of reproduction and development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gao LinglingDepartment of Obstetrics and Gynecology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Jiangsu 225001, China.
Yang QingxingDepartment of Obstetrics and Gynecology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Jiangsu 225001, China.
Xu JianboDepartment of Obstetrics and Gynecology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Jiangsu 225001, China.
Wang WeijieDepartment of Obstetrics and Gynecology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Jiangsu 225001, China.
Lu DanDepartment of Obstetrics and Gynecology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Jiangsu 225001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MiR-145-5p has been implicated in the development and progression of various disorders, and it is primarily recognized as a tumor suppressor in numerous cancers types. Its expression has been reported to decrease in the granulosa cells of patients with polycystic ovarian syndrome (PCOS). This study aimed to investigate whether miR-145-5p plays a role in granulosa cell proliferation and to shed light on the underlying pathological mechanisms of follicular development in patients with PCOS. Follicular fluid samples were collected from patients with PCOS and healthy individuals. The Cell Counting Kit-8 and bromodeoxyuridine assays were performed to assess KGN cell proliferation. The expression of miR-145-5p was significantly decreased in PCOS granulosa cells than in control cells, whereas the expression of SET was increased. Furthermore, miR-145-5p suppressed the proliferation of KGN cells. SET was identified as a direct target of miR-145-5p. Additionally, SET promoted the proliferation of KGN cells, and knockdown of SET counteracted the effect of the miR-145-5p inhibitor. Therefore, miR-145-5p regulates granulosa cell proliferation by targeting the SET in KGN cells; this process may be a potential pathological pathway that contributes to follicular developmental disorders in PCOS.

Indexed as

Cell ProliferationGranulosa CellsMicroRNAsPolycystic Ovary SyndromeAdultCell LineFemaleFollicular FluidGene Expression RegulationHumansTranscription FactorsMicroRNAsMIRN145 microRNA, humanTranscription FactorsGranulosa cell proliferationMiR-145-5pSET

Identifiers

PMID39313372
PMCPMC11658921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.